2018-11-01から1ヶ月間の記事一覧
Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma. N Engl J Med. 2018 Nov 8;379(19):1811-1822 PMID: 30403938, doi: 10.1056/NEJMoa1805762. 背景 免疫賦活性モノクローナル抗体であるエロツズマブにレナリドミドとデキサメタゾンを…
Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial. Lance…
Long-term efficacy of reduced-intensity versus myeloablative conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: retrospective follow-up of an open-label, r…
Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma. N Engl J Med. 2018 Sep 6;379(10):934-947. 背景 リツキシマブと化学療法の併用は，治療歴が無い進行期の濾胞性リンパ腫に有効であることが示されている。それにもかかわらず，ほ…
